Financials

  • Market Capitalization 1.66 B
  • Employee 140
  • Founded 2011
  • CEO N/A
  • Website www.absci.com
  • Headquarter Washington, United States
  • FIGI BBG011N54CJ8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.15
Rapporto prezzo/fatturato
170.48

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2060
GPCR
Structure Therapeutics Inc - American Depositary Shares
23.91 USD-6.38%-13.21%-38.57%-10.58%1.71 B USD
2082
OCUL
Ocular Therapeutix, Inc. - Common Stock
7.56 USD+0.27%+3.56%-28.75%-34.26%1.66 B USD
2125
STOK
Stoke Therapeutics, Inc. - Common Stock
24.15 USD-2.38%-5.59%-17.80%-20.48%1.56 B USD
2128
INVA
Innoviva, Inc. - Common Stock
21.45 USD+1.13%+3.22%+2.48%+20.37%1.55 B USD

Notizie